Skip to main content

Table 1 Studies included in this systematic review. Values for age and disease duration are presented as the mean value ± standard deviation, mean value (range) or percentage

From: Oral health-related quality of life in adult patients with end-stage kidney diseases undergoing renal replacement therapy – a systematic review

Author, yearDiseaseCountryNo. of patientsStudy typeSubjects mean age in yearsDisease durationFemale (%)Control group for OHRQoL
Guzeldemir et al. 2009 [17]HDTurkey47monocentric cross-sectional46.38 ± 15.10 yearsHD: 71.04 ± 1.16 months48.9%no
Hajian-Tilaki et al. 2014 [18]HDIran145monocentric cross-sectional58.17 ± 17.76 yearsHD: 49.33 ± 46.99 months46.9%no
Pakpour et al. 2015 [19]HDIran512multicentre cross-sectional57.7 ± 17.01HD: 52.12 ± 29.86 months37.1%yes, healthy control n = 255, 55.8 ± 15.9 years, 38% female
Schmalz et al. 2016 [20]HD, KTxGermanyHD: 87, KTx: 39multicentre cross-sectionalHD: 60.98 ± 14.01 years, KTx: 56.51 ± 11.56 yearsn/aHD: 37.9% KTx: 51.3%yes, healthy control n = 91, age: 58.31 ± 9.91 years, 65.9% female
Lopez-Pintor et al. 2017 [21]HDSpain50monocentric cross-sectional66.62 ± 13.96 yearsHD: 46.02 ± 44.90 months30%no
Lira E Silva et al. 2017 [28]HDBrazil226multicentre cross-sectional55.52 ± 14.70HD: < 1 year: 17.3%, 1–5 years: 56.6%, > 5 years 26.1%40.7%no
Rodakowska et al. 2018 [22]HDPoland72monocentric cross-sectional63.2 ± 15.2 yearsHD: 43.8 (1–264) months60.7%no
Camacho-Alonso et al. 2018 [23]HDSpain120multicentre cross-sectional69.90 ± 11.61 yearsHD: < 1 year: 11.7%, 1–2.9 years: 10.8%, 3–4.9 years: 22.5%, 5–9.9 years: 35.8%, > 10 years: 19.2%31.7%yes, healthy control n = 120, mean age 67.71 ± 8.96, 37.5% female
Schmalz et al. 2018 [24]HDGermany210multicentre cross-sectional64.92 ± 15.7 yearsHD: 0–2 years: 15.3%, 3–5 years: 18.4%, 6–8 years 17.9%, 9–12 years 15.3%, 13–20 years 17.9%, > 20 years: 15.3%35%no
Ruokonen et al. 2019 [25]KTxFinland51prospective follow-up cohort study61 (31–86) yearstime since KTx 7.1 (1–11) years33%no
Kahar et al. 2019 [26]HDUSA70multicentre cross-sectional≤65 years: 44.1% > 66 years: 55.9%4.7 ± 7.5 years39.7%no
Oliveira et al. 2019 [27]HDBrazil180multicentre cross-sectional51.98 ± 14.34 years< 12 months: 23.3%, 12–36 months 32.7%, > 36 months45%no
  1. OHRQoL oral health-related quality of life, n/a not applicable, HD haemodialysis, KTx kidney transplantation